MYLAN PHARMS INC FDA Approval ANDA 091537

ANDA 091537

MYLAN PHARMS INC

FDA Drug Application

Application #091537

Application Sponsors

ANDA 091537MYLAN PHARMS INC

Marketing Status

Discontinued001
Discontinued002
Discontinued003
Discontinued004
Discontinued005
Discontinued006

Application Products

001TABLET, ORALLY DISINTEGRATING;ORAL0.5MG0RISPERIDONERISPERIDONE
002TABLET, ORALLY DISINTEGRATING;ORAL1MG0RISPERIDONERISPERIDONE
003TABLET, ORALLY DISINTEGRATING;ORAL2MG0RISPERIDONERISPERIDONE
004TABLET, ORALLY DISINTEGRATING;ORAL3MG0RISPERIDONERISPERIDONE
005TABLET, ORALLY DISINTEGRATING;ORAL4MG0RISPERIDONERISPERIDONE
006TABLET, ORALLY DISINTEGRATING;ORAL0.25MG0RISPERIDONERISPERIDONE

FDA Submissions

ORIG1AP2011-03-30
MANUF (CMC); Manufacturing (CMC)SUPPL2AP2013-02-12
LABELING; LabelingSUPPL3AP2013-03-22
LABELING; LabelingSUPPL4AP2012-12-13STANDARD
LABELING; LabelingSUPPL6AP2014-11-28STANDARD
LABELING; LabelingSUPPL9AP2020-10-28STANDARD
LABELING; LabelingSUPPL10AP2020-10-28STANDARD

Submissions Property Types

ORIG1Null7
SUPPL2Null0
SUPPL3Null15
SUPPL4Null15
SUPPL6Null7
SUPPL9Null15
SUPPL10Null7

CDER Filings

MYLAN PHARMS INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 91537
            [companyName] => MYLAN PHARMS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"RISPERIDONE","activeIngredients":"RISPERIDONE","strength":"0.5MG","dosageForm":"TABLET, ORALLY DISINTEGRATING;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"RISPERIDONE","activeIngredients":"RISPERIDONE","strength":"1MG","dosageForm":"TABLET, ORALLY DISINTEGRATING;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"RISPERIDONE","activeIngredients":"RISPERIDONE","strength":"2MG","dosageForm":"TABLET, ORALLY DISINTEGRATING;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"RISPERIDONE","activeIngredients":"RISPERIDONE","strength":"3MG","dosageForm":"TABLET, ORALLY DISINTEGRATING;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"RISPERIDONE","activeIngredients":"RISPERIDONE","strength":"4MG","dosageForm":"TABLET, ORALLY DISINTEGRATING;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"RISPERIDONE","activeIngredients":"RISPERIDONE","strength":"0.25MG","dosageForm":"TABLET, ORALLY DISINTEGRATING;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"RISPERIDONE","submission":"RISPERIDONE","actionType":"0.5MG","submissionClassification":"TABLET, ORALLY DISINTEGRATING;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"RISPERIDONE","submission":"RISPERIDONE","actionType":"1MG","submissionClassification":"TABLET, ORALLY DISINTEGRATING;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"RISPERIDONE","submission":"RISPERIDONE","actionType":"2MG","submissionClassification":"TABLET, ORALLY DISINTEGRATING;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"RISPERIDONE","submission":"RISPERIDONE","actionType":"3MG","submissionClassification":"TABLET, ORALLY DISINTEGRATING;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"RISPERIDONE","submission":"RISPERIDONE","actionType":"4MG","submissionClassification":"TABLET, ORALLY DISINTEGRATING;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"RISPERIDONE","submission":"RISPERIDONE","actionType":"0.25MG","submissionClassification":"TABLET, ORALLY DISINTEGRATING;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.